These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34085042)
1. A structure-kinetic relationship study using matched molecular pair analysis. Schuetz DA; Richter L; Martini R; Ecker GF RSC Med Chem; 2020 Sep; 11(11):1285-1294. PubMed ID: 34085042 [TBL] [Abstract][Full Text] [Related]
2. Impact, determination and prediction of drug-receptor residence times for GPCRs. Tautermann CS Curr Opin Pharmacol; 2016 Oct; 30():22-26. PubMed ID: 27428776 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors. Spagnuolo LA; Eltschkner S; Yu W; Daryaee F; Davoodi S; Knudson SE; Allen EK; Merino J; Pschibul A; Moree B; Thivalapill N; Truglio JJ; Salafsky J; Slayden RA; Kisker C; Tonge PJ J Am Chem Soc; 2017 Mar; 139(9):3417-3429. PubMed ID: 28151657 [TBL] [Abstract][Full Text] [Related]
4. Ligand Desolvation Steers On-Rate and Impacts Drug Residence Time of Heat Shock Protein 90 (Hsp90) Inhibitors. Schuetz DA; Richter L; Amaral M; Grandits M; Grädler U; Musil D; Buchstaller HP; Eggenweiler HM; Frech M; Ecker GF J Med Chem; 2018 May; 61(10):4397-4411. PubMed ID: 29701469 [TBL] [Abstract][Full Text] [Related]
5. Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor. Xia L; de Vries H; IJzerman AP; Heitman LH Purinergic Signal; 2016 Mar; 12(1):115-26. PubMed ID: 26647040 [TBL] [Abstract][Full Text] [Related]
6. On-rate based optimization of structure-kinetic relationship--surfing the kinetic map. Schoop A; Dey F Drug Discov Today Technol; 2015 Oct; 17():9-15. PubMed ID: 26724331 [TBL] [Abstract][Full Text] [Related]
7. KinITC-One Method Supports both Thermodynamic and Kinetic SARs as Exemplified on FimH Antagonists. Zihlmann P; Silbermann M; Sharpe T; Jiang X; Mühlethaler T; Jakob RP; Rabbani S; Sager CP; Frei P; Pang L; Maier T; Ernst B Chemistry; 2018 Sep; 24(49):13049-13057. PubMed ID: 29939458 [TBL] [Abstract][Full Text] [Related]
8. Structure-kinetic relationship studies of cannabinoid CB Soethoudt M; Hoorens MWH; Doelman W; Martella A; van der Stelt M; Heitman LH Biochem Pharmacol; 2018 Jun; 152():129-142. PubMed ID: 29574067 [TBL] [Abstract][Full Text] [Related]
9. Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time. Guo D; IJzerman AP Methods Mol Biol; 2018; 1705():197-206. PubMed ID: 29188564 [TBL] [Abstract][Full Text] [Related]
10. Machine Learning Analysis of τRAMD Trajectories to Decipher Molecular Determinants of Drug-Target Residence Times. Kokh DB; Kaufmann T; Kister B; Wade RC Front Mol Biosci; 2019; 6():36. PubMed ID: 31179286 [TBL] [Abstract][Full Text] [Related]
11. Design strategies to address kinetics of drug binding and residence time. Cusack KP; Wang Y; Hoemann MZ; Marjanovic J; Heym RG; Vasudevan A Bioorg Med Chem Lett; 2015; 25(10):2019-27. PubMed ID: 25782745 [TBL] [Abstract][Full Text] [Related]
12. Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase. Neckles C; Eltschkner S; Cummings JE; Hirschbeck M; Daryaee F; Bommineni GR; Zhang Z; Spagnuolo L; Yu W; Davoodi S; Slayden RA; Kisker C; Tonge PJ Biochemistry; 2017 Apr; 56(13):1865-1878. PubMed ID: 28225601 [TBL] [Abstract][Full Text] [Related]
13. Avidity and positive allosteric modulation/cooperativity act hand in hand to increase the residence time of bivalent receptor ligands. Vauquelin G; Bricca G; Van Liefde I Fundam Clin Pharmacol; 2014 Oct; 28(5):530-43. PubMed ID: 24118041 [TBL] [Abstract][Full Text] [Related]
15. Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists. Vilums M; Zweemer AJ; Yu Z; de Vries H; Hillger JM; Wapenaar H; Bollen IA; Barmare F; Gross R; Clemens J; Krenitsky P; Brussee J; Stamos D; Saunders J; Heitman LH; Ijzerman AP J Med Chem; 2013 Oct; 56(19):7706-14. PubMed ID: 24028535 [TBL] [Abstract][Full Text] [Related]
16. Kinetics for Drug Discovery: an industry-driven effort to target drug residence time. Schuetz DA; de Witte WEA; Wong YC; Knasmueller B; Richter L; Kokh DB; Sadiq SK; Bosma R; Nederpelt I; Heitman LH; Segala E; Amaral M; Guo D; Andres D; Georgi V; Stoddart LA; Hill S; Cooke RM; De Graaf C; Leurs R; Frech M; Wade RC; de Lange ECM; IJzerman AP; Müller-Fahrnow A; Ecker GF Drug Discov Today; 2017 Jun; 22(6):896-911. PubMed ID: 28412474 [TBL] [Abstract][Full Text] [Related]
17. A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands. Swinney DC; Beavis P; Chuang KT; Zheng Y; Lee I; Gee P; Deval J; Rotstein DM; Dioszegi M; Ravendran P; Zhang J; Sankuratri S; Kondru R; Vauquelin G Br J Pharmacol; 2014 Jul; 171(14):3364-75. PubMed ID: 24628038 [TBL] [Abstract][Full Text] [Related]
18. NMR-based screening methods for lead discovery. Vogtherr M; Fiebig K EXS; 2003; (93):183-202. PubMed ID: 12613177 [TBL] [Abstract][Full Text] [Related]
19. Prediction of the Drug-Target Binding Kinetics for Flexible Proteins by Comparative Binding Energy Analysis. Nunes-Alves A; Ormersbach F; Wade RC J Chem Inf Model; 2021 Jul; 61(7):3708-3721. PubMed ID: 34197096 [TBL] [Abstract][Full Text] [Related]